Anvisa suspends import of inputs Indian company Lupin Limited

Anvisa suspends import of inputs Indian company Lupin Limited

May 13, 2015 - Anvisa suspended imports of all beta-lactam cephalosporin pharmaceutical ingredients and all imported drugs that were manufactured using these inputs, which are manufactured by the Indian company Lupin Limited.

Analysis considered unsatisfactory inputs. Furthermore, irregularities were detected during the inspection for verification of Good Manufacturing Practices.

The measure is in Resolution No. 1430, published on Wednesday (13/5) in the Official Gazette (DOU).

Suggested Articles

The FDA asked five drugmakers to pull their version of extended-release metformin off U.S. shelves after finding carcinogen contamination.

The FDA backtracked on its earlier testing and found NDMA contamination in the extended release formulation of certain generic versions of metformin.

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.